Published in Breast Cancer on January 01, 2004
A robust automated measure of average antibody staining in immunohistochemistry images. J Histochem Cytochem (2010) 1.06
Multicolor multicycle molecular profiling with quantum dots for single-cell analysis. Nat Protoc (2013) 0.91
Single-band upconversion nanoprobes for multiplexed simultaneous in situ molecular mapping of cancer biomarkers. Nat Commun (2015) 0.86
Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol (2010) 2.18
Increased phosphorylation of Akt in triple-negative breast cancers. Cancer Sci (2007) 1.04
Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: HER2 gene amplification and p53 mutation. Int J Oncol (2003) 1.01
Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis. Gynecol Oncol (2006) 1.00
Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Pathol Int (2009) 0.99
Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem Mol Morphol (2004) 0.98
Pathology of pituitary tumors. Neurosurg Clin N Am (2003) 0.97
Papillary thyroid carcinoma with fibromatosis-like stroma: a report of two cases. Endocr Pathol (2002) 0.97
DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors. J Clin Endocrinol Metab (2013) 0.95
Olfactory neuroblastoma causing ectopic ACTH syndrome. Endocr J (2005) 0.94
Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character. Oncol Rep (2008) 0.93
Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma. Acta Histochem Cytochem (2013) 0.92
Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol (2004) 0.89
Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. J Obstet Gynaecol Res (2010) 0.88
Hypothesis for the mechanism for heat-induced antigen retrieval occurring on fresh frozen sections without formalin-fixation in immunohistochemistry. J Mol Histol (2008) 0.88
X-ray microtomographic imaging of three-dimensional structure of soft tissues. Tissue Eng Part C Methods (2008) 0.88
Myxoid leiomyoma of the vulva: a case report. Tokai J Exp Clin Med (2002) 0.88
Cocaine- and amphetamine-regulated transcript peptide in the rat anterior pituitary gland is localized in gonadotrophs and suppresses prolactin secretion. Endocrinology (2004) 0.88
Three-dimensional imaging of the intracellular localization of growth hormone and prolactin and their mRNA using nanocrystal (Quantum dot) and confocal laser scanning microscopy techniques. J Histochem Cytochem (2005) 0.88
What causes discrepancies in HER2 testing for breast cancer? A Japanese ring study in conjunction with the global standard. Am J Clin Pathol (2008) 0.87
Undifferentiated spindle and giant cell carcinoma of the common bile duct. Tokai J Exp Clin Med (2003) 0.87
Granulogenesis in non-neuroendocrine COS-7 cells induced by EGFP-tagged chromogranin A gene transfection: identical and distinct distribution of CgA and EGFP. J Histochem Cytochem (2007) 0.85
Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors. Oncol Rep (2002) 0.84
Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol (2002) 0.84
Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression. Arch Gynecol Obstet (2008) 0.83
Microtomographic analysis of neuronal circuits of human brain. Cereb Cortex (2009) 0.83
Submicrometer tomographic resolution examined using a micro-fabricated test object. Micron (2009) 0.83
Identification of transcriptional regulatory elements in the human somatostatin receptor sst2 promoter and regions including estrogen response element half-site for estrogen activation. J Mol Endocrinol (2008) 0.83
Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1. Arch Gynecol Obstet (2008) 0.82
Expression of GATA-2 in human pituitary adenomas. Mod Pathol (2002) 0.82
Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH). Pathol Int (2010) 0.82
Quantification of neutral cysteine protease bleomycin hydrolase and its localization in rat tissues. J Biochem (2006) 0.82
Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinoma. Pathol Int (2002) 0.81
An up-to-date anti-cancer treatment strategy focusing on HIF-1alpha suppression: its application for refractory ovarian cancer. Acta Histochem Cytochem (2007) 0.81
Sevoflurane stimulates MAP kinase signal transduction through the activation of PKC alpha and betaII in fetal rat cerebral cortex cultured neuron. Acta Histochem Cytochem (2006) 0.81
Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer. Int J Oncol (2004) 0.81
Association of hepatocyte growth factor expression with salivary gland tumor differentiation. Pathol Int (2003) 0.79
PTTG overexpression is correlated with angiogenesis in human pituitary adenomas. Endocr Pathol (2006) 0.79
Renal cell carcinoma arising in a long pre-existing angiomyolipoma. Pathol Int (2007) 0.79
Case of uterine cervical carcinosarcoma. J Obstet Gynaecol Res (2005) 0.79
Impaired regulation of gonadotropins leads to the atrophy of the female reproductive system in klotho-deficient mice. Endocrinology (2005) 0.79
Analyses of the mechanism of intracellular transport and secretion of pituitary hormone, with an insight of the subcellular localization of pituitary hormone and its mRNA. Brain Tumor Pathol (2006) 0.78
Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules. Pathol Res Pract (2003) 0.78
Kinobeon A as a potent tyrosinase inhibitor from cell culture of safflower: in vitro comparisons of kinobeon A with other putative inhibitors. Planta Med (2003) 0.77
Phosphorylation of cAMP response element binding protein (CREB) as a marker of hypoxia in pituitary adenoma. J Neurooncol (2006) 0.77
Establishment of stable GH3 cell line expressing enhanced yellow fluorescein protein-growth hormone fusion protein. J Histochem Cytochem (2005) 0.77
Co-transfection of EYFP-GH and ECFP-rab3B in an experimental pituitary GH3 cell: a role of rab3B in secretion of GH through porosome. Folia Histochem Cytobiol (2008) 0.77
Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma. Oncol Rep (2004) 0.76
Dynamics of subcellular organelles, growth hormone, Rab3B, SNAP-25, and syntaxin in rat pituitary cells caused by growth hormone releasing hormone and somatostatin. Microsc Res Tech (2003) 0.76
Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type. Pathol Int (2003) 0.76
Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Med Mol Morphol (2013) 0.76
Molecular morphology of pituitary cells, from conventional immunohistochemistry to fluorescein imaging. Molecules (2011) 0.76
Malignant gastric carcinoid causing ectopic ACTH syndrome: discrepancy of plasma ACTH levels measured by different immunoradiometric assays. Endocr J (2005) 0.76
Immunohistochemical analysis of neuroendocrine (NE) differentiation in testicular germ cell tumors (GCTs): use of confocal laser scanning microscopy (CLSM) to demonstrate direct NE differentiation from GCTs. Acta Histochem Cytochem (2007) 0.75
Treatment strategy for recurrent and refractory epithelial ovarian cancer: efficacy of high-dose chemotherapy with hematopoietic stem cell transplantation. Acta Histochem Cytochem (2006) 0.75
Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation. Pathol Int (2004) 0.75
Uterine body cancer mass screening at Tokai University Hospital. Tokai J Exp Clin Med (2004) 0.75
Functional molecular morphology of anterior pituitary cells, from hormone production to intracellular transport and secretion. Med Mol Morphol (2011) 0.75
Immunohistochemical evaluation of hormone receptor for routine practice of breast cancer: highly sensitive procedures significantly contribute to the correlation with biochemical assays. Appl Immunohistochem Mol Morphol (2003) 0.75
Screening program of prostate cancer at Tokai University Hospital: characterization of prostate-specific antigen measurement. Tokai J Exp Clin Med (2005) 0.75
Bronchial carcinoid tumor with gangliocytic- and paraganglionlike differentiation. Virchows Arch (2003) 0.75
A resectable case of gastrointestinal stromal tumor derived from the rectal wall after oral targeted molecular therapy with imatinib mesylate. Tokai J Exp Clin Med (2006) 0.75
Dietary soybean enhances Pit-1 dependent pituitary hormone production in iodine deficient rats. J Mol Histol (2005) 0.75
Cytologic three-dimensional imaging for the interpretation of staining profiles: application of confocal laser scanning microscopy. Diagn Cytopathol (2004) 0.75
Association of neuroendocrine differentiation with neoadjuvant hormone therapy effects in prostatic cancer. Oncol Rep (2005) 0.75
Three-dimensional microtomographic imaging of human brain cortex. Brain Res (2008) 0.75
Progression of 189 women diagnosed with uterine cervical dysplasia based on abnormal results in mass screening. Tokai J Exp Clin Med (2006) 0.75